PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 186 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2014. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,730,000 | +96.4% | 17,500 | -41.7% | 1.13% | +248.9% |
Q1 2016 | $881,000 | -55.1% | 30,000 | +20.0% | 0.32% | -49.9% |
Q4 2015 | $1,960,000 | -66.8% | 25,000 | 0.0% | 0.64% | -74.0% |
Q1 2015 | $5,903,000 | +211.8% | 25,000 | +150.0% | 2.48% | +171.4% |
Q4 2014 | $1,893,000 | -20.7% | 10,000 | 0.0% | 0.92% | -28.2% |
Q3 2014 | $2,386,000 | +31.5% | 10,000 | -63.6% | 1.27% | +50.4% |
Q2 2014 | $1,815,000 | -50.2% | 27,500 | -21.4% | 0.85% | -49.7% |
Q1 2014 | $3,645,000 | +40.8% | 35,000 | +40.0% | 1.68% | +14.2% |
Q4 2013 | $2,588,000 | – | 25,000 | – | 1.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
Leap Investments LP | 29,100 | $370,000 | 0.50% |
Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |